What to expect from Gossamer Bio’s late-stage lung disease study Plus: ProMis Neurosciences takes its shot at a better, safer Alzheimer’s treatment By Adam FeuersteinFeb. 19, 2026 Senior Writer, Biotech

https://www.statnews.com/2026/02/19/gossamer-bio-promis-neurosciences/